387. Myeloid Sarcoma Associated with Gene Marking of Hematopoietic Stem Cells in a Rhesus Macaque
Tags: ABSTRACTS; HEMATOPOIETIC stem cells -- Abstracts
Related Articles
- The CD34 Antigen Molecular Domains Implied in Potential Homing and Engraftment of Hematopoietic Progenitors. // Molecular Therapy;May2004 Supplement 1, Vol. 9, p246
An abstract of the article "The CD34 Antigen Molecular Domains Implied in Potential Homing and Engraftment of Hematopoietic Progenitors," by Gurudutta U. Gangenahalli, Vimal K. Singh, Soumya Pati, Yogesh K. Verma,1 Pallavi Gupta, Rajat Kumar, Rakesh K. Sharma, and Pratibha M. Luthra is presented.
- A SIN lentiviral vector that allows in vivo drug-selection of hematopoietic stem cells yet retains erythroid-specific expression of the ferrochelatase gene and results in cure of murine protoporphyria. // Molecular Therapy;May2004 Supplement 1, Vol. 9, p266
An abstract of the article "A SIN Lentiviral Vector That Allows In Vivo Drug-Selection of Hematopoietic Stem Cells yet Retains Erythroid-Specific Expression of the Ferrochelatase Gene and Results in Cure of Murine Protoporphyria," by Emmanuel Richard, Elodie Robert, Muriel Cario-Andre, Cecile...
- Efficient in vivo gene marking of hematopoietic cells without marrow conditioning in nonhuman primates. // Molecular Therapy;May2004 Supplement 1, Vol. 9, p267
An abstract of the article "Efficient In Vivo Gene Marking of Hematopoietic Cells without Marrow Conditioning in Nonhuman Primates," by Kyouji Ueda, Yasuji Ueda, Yutaka Hanazonno, Hiroaki Shibata, Naohide Ageyama, Takeyuki Nagashima, Toshiaki Tabata, Akihiro Kume, Susumu Ikehara, Keiji Terao,...
- 401. Evaluation of Primitive Murine Hematopoietic Stem and Progenitor Cell Transduction In Vitro and In Vivo by Recombinant Adeno-Associated Virus Vectors Based on Serotypes 1 through 5. Zhong, Li; Li, Weiming; Li, Yanjun; Qing, Keyun; Yoder, Mervin C.; Srivastava, Arun // Molecular Therapy;Jun2005, Vol. 11, p155
An abstract of the article "Evaluation of Primitive Murine Hematopoietic Stem and Progenitor Cell Transduction In Vitro and In Vivo by Recombinant Adeno-Associated Virus Vectors Based on Serotypes 1 through 5," by Li Zhong, Weiming Li, Yanjun Li, Keyun Qing and Mervin C. is presented.
- 927. Human Mesenchymal and Hematopoietic Stem Cell Contribution to Cardiac Tissue Regeneration after Injury. Rosova, Ivana; Nolta, Jan A. // Molecular Therapy;Jun2005, Vol. 11, p358
An abstract of the article "Human Mesenchymal and Hematopoietic Stem Cell Contribution to Cardiac Tissue Regeneration after Injury," by Ivana Rosova and colleagues is presented.
- Epstein - Barr virus - associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation. Xiu-li Wu; Qi-fa Liu // Journal of Hematology & Oncology;2012 Supplement 1, Vol. 5 Issue Suppl 1, p1
An abstract of the article "Epstein-Barr virus-associated Diseases in Allogeneic Hematopoietic Stem Cell Transplantation," by Xiu-li Wu and Qi-fa Liu.
- Hematopoietic stem cells for neovascularization and wound repair. Iacopino, P.; Lombardo, M. F.; Cuzzola, M.; Irrera, G.; Spiniello, E.; Garreffa, C.; Saccardi, R.; Piro, R.; Grossi, G.; Fiasché, M.; Mannino, D.; Verma, A.; Morabito, C.; Kasabov, N. // BMC Geriatrics;2010 Supplement 1, Vol. 10, pA109
An abstract of the article "Hematopoietic Stem Cells for Neovascularization and Wound Repair," by M. F. Lombardo and colleagues is presented.
- Molecular Long-Term Follow Up in Non-Human Primates That Received Retrovirally Transduced Stem Cells: Despite Proto-Oncogene Insertion No Leukemia or Hematopoietic Abnormalities. // Molecular Therapy;May2004 Supplement 1, Vol. 9, p1
An abstract of the article "Molecular Long-Term Follow Up in Non-Human Primates That Received Retrovirally Transduced Stem Cells: Despite Proto-Oncogene Insertion No Leukemia or Hematopoietic Abnormalities," by Brian C. Beard and colleagues is presented.
- Potent Cancer Immunotherapy with Dendritic Cells Generated from Genetically Modified Hematopoietic Stem Cells. // Molecular Therapy;May2004 Supplement 1, Vol. 9, p98
An abstract of the article "Potent Cancer Immunotherapy with Dendritic Cells Generated from Genetically Modified Hematopoietic Stem Cells," by Tsukasa Nabekura, Hiromitsu Nakauchi, Toshirou Nagasawa and Masafumi Onodera is presented.
